Robert H. Pudenz award

Awarding excellence in cerebrospinal fluid and hydrocephalus research

Our commitment to collaboration

The development of cutting-edge medical technology, as well as the improvement of existing products, is a collaborative process between medical device companies, physicians, and medical institutions. Medtronic is committed to continuing collaboration with physicians and their institutions in the form of donations of money and other types of sponsorships, such as programs designed to educate and train physicians to allow them and their institutions to bring life-saving and life-enhancing therapies to patients worldwide.

The Pudenz Award is a research grant awarded to the academic or clinical institution with which the nominee is affiliated, demonstrating a commitment to advancing the science of the field of CSF physiology and hydrocephalus through research published in peer-reviewed journals. The recipient of the award is chosen by an independent Committee based on the extensive nature of the research work conducted by the recipient.

The award has been given since 1988 in honor of Robert H. Pudenz, one of the founders of the PS Medical Corporation (now Medtronic). He was a recognized pioneer in the field of pediatric neurosurgery. His area of research was in cerebrospinal fluid physiology and shunt technology for the treatment of hydrocephalus.

Robert Pudenz

Image credit: HMRI.org

2023 award recipient

Professor Roger Bayston, from the School of Medicine, Biomaterials-Related Infection Group, University of Nottingham, has made many contributions to developing and understanding the value of antibiotic-impregnated hydrocephalus shunt catheters. These local and international contributions have helped move awareness of the significance of shunt infection forward in the medical community. A review of his publications by the Pudenz Award Selection Committee confirmed the seminal role Prof. Bayston has played in the development of antibiotic-impregnated catheters and their value in the treatment of shunt infection, significantly lowering shunt infections and improving the quality of life for thousands of patients. The value of his findings has been proven in several controlled trial studies.

Selection Committee
(2015-Current)

  • Marion L. (Jack) Walker, M.D.
  • James P. (Pat) McAllister II, Ph.D.
  • Marc R. Del Bigio, M.D., Ph.D.
  • Conrad E. Johanson, Ph.D.
  • John D. Pickard, M.D., Ph.D.
Professor Roger Bayston

Professor
Roger Bayston

Britain

Past award winners

Year Awardee Country 
2020 Jan Malm, Ph.D.. & Anders Eklund, Ph.D. Sweden
2017 Carsten Wikkelslo Sweden
2015 Michael Williams United States
2013 John R.W. Kestle, M.D. United States
2011 Esteban M. Rodriguez, M.D., Ph.D. Chile
2010 Marek Czosnyka, Ph.D. United Kingdom
2009 Marc R. Del Bigio, M.D., Ph.D. Canada
2008 Anthony Marmarou, Ph.D. United States
2007 Hazel Cordelia Jones, Ph.D. United Kingdom
2006 Miles Gregory Johnston, Ph.D. Canada
2005 James Patterson McAllister II, Ph.D. United States
2004 Conrad Earl Johanson, Ph.D. United States
2003 Salomon Hakin, M.D. Colombia
2002 Sven Erik Borgensen, M.D. Denmark
2001 Kiyoshi Sato, M.D. Japan
2000 John D. Pickard, M.D. United Kingdom
1999 Christian Sainte-Rose, M.D. France
1998 Harold D. Portnoy, M.D. United States
1997 Flemming Gjerris, M.D., DSc Denmark
1996 Concezio Di Rocco, M.D. Italy
1995 David G. McLone, M.D. United States
1994 Bernard Williams, FRCS United Kingdom
1994 Thomas H. Milhorat, M.D. United States
1993 Harold Rekate, M.D. United States
1992 Maurice Choux, M.D. France
1991 Michael Pollay, M.D., FAANS(L) United States
1991 Ismail El Shafei, M.D. Egypt
1990 J. Gordon McComb, M.D. United States
1990 Alfred Aschoff, M.D. Germany
1990 Shizuo Oi, M.D. Japan
1990 Satoshi Matsumoto, M.D. Japan
1989 James Drake, M.D. Canada
1988 Isam Awad, M.D. United States
 
 

CSF shunt products

Learn more about Medtronic cerebrospinal fluid (CSF)
shunt products and technology.

Learn more